| Kyle Weiss, PHARM D | |
|
1323 Bia Route 4, Fort Thompson, SD 57339-0200 | |
| (605) 245-1534 | |
| Not Available |
| Full Name | Kyle Weiss |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1323 Bia Route 4, Fort Thompson, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912453622 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 6384 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kyle Weiss, PHARM D Po Box 200, Fort Thompson, SD 57339-0200 Ph: () - | Kyle Weiss, PHARM D 1323 Bia Route 4, Fort Thompson, SD 57339-0200 Ph: (605) 245-1534 |
News Archive
Neoprobe Corporation a diversified developer of innovative oncology surgical and diagnostic products, today announced that Senior Vice President of Pharmaceutical Research and Clinical Development, Dr. Frederick O. Cope, presented information on the Company's lead pipeline initiative, Lymphoseek, at the International Symposium on Technetium and Other Radiometals in Chemistry and Medicine (TERACHEM), held September 8-11, 2010 in Bressanone (Bolzano), Italy.
Paclitaxel is a powerful anticancer agent used to treat a variety of malignancies, but severe side effects limit its ultimate effectiveness and utility. To improve this drug's pharmacological properties, researchers have turned to nanoparticle-based delivery agents, although with marginal success; stably trapping large amounts of paclitaxel in most nanoparticles has proven difficult.
It's a bit of a challenge. But, imagine a microscopic jet vacuum cleaner, the size of a pen nib that hovers over cell surfaces without ever touching them. Then imagine that the soap in the cleaning solution is replaced with various molecules that can be selectively delivered to the cells. This gives you a sense of a new device that researchers believe will serve as a powerful tool to study the behaviour of living cells and a range of crucial cellular processes, from cancer cell formation to how neurons align themselves in the developing brain.
The European Society of Cardiology (ESC) welcomes the spotlight that a US study has placed on the importance of measuring rates of rehospitalisation following percutaneous coronary intervention (PCI) procedures.
New biomarkers will improve diagnostics of endemic diseases in future, such as prostate cancer. Their mission: to recognize the tumor earlier and classify it more precisely - thereby helping avoid unnecessary operations.
› Verified 3 days ago
Mr. David Alan Zimbrick, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1323 Bia Route 4, Fort Thompson, SD 57339 Phone: 605-245-1554 | |
Dr. Jwan M Mustafa, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1323 Bia Route 4, Fort Thompson, SD 57339 Phone: 605-245-1540 | |
Dr. Mark S Foster, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1323 Bia Route 4, Fort Thompson, SD 57339 Phone: 605-245-1534 | |
Christina Marie Odens, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1323 Bia Route 4, Fort Thompson, SD 57339 Phone: 605-245-1554 Fax: 605-245-2384 | |
Dr. Jacquie Roth, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Highway 34 & 47, Fort Thompson, SD 57339 Phone: 605-245-1503 | |
Michelle Duana Tuohy, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1323 Bia Route 4, Fort Thompson, SD 57339 Phone: 605-245-2285 Fax: 605-245-2384 |